Everhart Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Everhart Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,717	Closed	-$9.49K	–	214
2022 Q4	$9.49K	Sell	10,717 -1,000	-9%	-$1.33K	﹤0.01%	180
2022 Q3	$19K	Hold	11,717	–	–	0.01%	201
2022 Q2	$24K	Buy	11,717 +1,000	+9%	+$1.73K	0.01%	186
2022 Q1	$25K	Hold	10,717	–	–	0.01%	131
2021 Q4	$50K	Hold	10,717	–	–	0.03%	107
2021 Q3	$82K	Hold	10,717	–	–	0.06%	100
2021 Q2	$104K	Buy	+10,717	New	+$85.3K	0.07%	94

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return